Methotrexate Tablets IP 5 Mg - NIVOTRAX 5 Tablets

NIVOTRAX 5 Tablets
Composition:- Methotrexate 5 Mg

NIVOTRAX 5 Tablets – Methotrexate Tablets IP 5 Mg contains methotrexate, a disease-modifying antirheumatic drug (DMARD) and antimetabolite that works by inhibiting dihydrofolate reductase, an enzyme involved in DNA synthesis and immune cell proliferation. This mechanism:
Reduces inflammation and modulates immune response in rheumatoid arthritis and psoriasis.
Slows down the growth of rapidly dividing cancer cells, making it effective in leukemia, lymphoma, and solid tumors.
Controls autoimmune diseases by suppressing overactive immune responses, preventing further joint and skin damage.

Key Points of Methotrexate Tablets IP 5 Mg – NIVOTRAX 5 Tablets
• Trusted Standard in Autoimmune & Cancer Care – Provides effective treatment for rheumatoid arthritis, psoriasis, and select cancers by controlling abnormal cell growth and moderating immune activity.
• Folate Pathway Blocker for Precision Therapy – Inhibits dihydrofolate reductase (DHFR), disrupting DNA synthesis to lower inflammation and slow disease progression in autoimmune conditions.
• Proven Efficacy with Monitored Dosing – Offers reliable results in long-term use, with carefully adjusted doses that maximize benefits while minimizing risks.

Can be Prescribed by:
• Rheumatologists 
• Dermatologists 
• Hematologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.